The relative potencies of cholinomimetics and muscarinic antagonists on the rat iris in vivo: effects of pH on potency of pirenzepine and telenzepine

[1]  R. Danesi,et al.  Differential affinities of AF-DX 116, atropine and pirenzepine for muscarinic receptors of guinea pig gastric fundus, atria and urinary bladder: might atropine distinguish among muscarinic receptor subtypes? , 1990, Pharmacology.

[2]  G. Schmidt,et al.  Tricyclic compounds as selective antimuscarinics. 2. Structure-activity relationships of M1-selective antimuscarinics related to pirenzepine. , 1988, Journal of medicinal chemistry.

[3]  G. Grass,et al.  Mechanisms of corneal drug penetration. I: In vivo and in vitro kinetics. , 1988, Journal of pharmaceutical sciences.

[4]  G. Grass,et al.  Mechanisms of corneal drug penetration. III: Modeling of molecular transport. , 1988, Journal of pharmaceutical sciences.

[5]  G. Grass,et al.  Mechanisms of corneal drug penetration. II: Ultrastructural analysis of potential pathways for drug movement. , 1988, Journal of pharmaceutical sciences.

[6]  C. Broekkamp,et al.  Pharmacological evaluation of in vivo tests for alpha 2-adrenoceptor blockade in the central nervous system and the effects of the enantiomers of mianserin and its aza-analog ORG 3770. , 1988, Archives internationales de pharmacodynamie et de therapie.

[7]  C. Schauf,et al.  Tetrahydroaminoacridine blocks potassium channels and inhibits sodium inactivation in Myxicola. , 1987, The Journal of pharmacology and experimental therapeutics.

[8]  H. Ladinsky,et al.  Characterization of the muscarinic receptor subtype in isolated gastric fundic cells of the rabbit. , 1987, Biochemical pharmacology.

[9]  C. Cotman,et al.  Excitatory actions of tetrahydro-9-aminoacridine (THA) on hippocampal pyramidal neurons , 1987, Neuroscience Letters.

[10]  G. Schmidt,et al.  Tricyclic compounds as selective antimuscarinics. 1. Structural requirements for selectivity toward the muscarinic acetylcholine receptor in a series of pirenzepine and imipramine analogues. , 1987, Journal of medicinal chemistry.

[11]  M. V. van Vugt,et al.  Differential interactions of muscarinic drugs with binding sites of [3H]pirenzepine and [3H]quinuclidinyl benzilate in rat brain tissue. , 1987, Life sciences.

[12]  R. Eglen,et al.  Competitive and non‐competitive antagonism exhibited by ‘selective’ antagonists at atrial and ileal muscarinic receptor subtypes , 1987, British journal of pharmacology.

[13]  H. Doods,et al.  In vivo potencies of selective muscarinic antagonists support the subdivision of m receptors into m 1 m 2 and m 3 subtypes , 1987 .

[14]  J. Wess,et al.  Stimulation of ganglionic muscarinic M1 receptors by a series of tertiary arecaidine and isoarecaidine esters in the pithed rat. , 1987, European journal of pharmacology.

[15]  R. Aronstam,et al.  High-affinity agonist binding to rat brainstem muscarinic receptors is eliminated by low pH , 1986, Neuroscience Letters.

[16]  A. Giachetti,et al.  Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonist. , 1986, Life sciences.

[17]  M. Koss,et al.  Pupillary dilation as an index of central nervous system alpha 2-adrenoceptor activation. , 1986, Journal of pharmacological methods.

[18]  J. Black,et al.  Pharmacological analysis of muscarinic receptors coupled to oxyntic cell secretion in the mouse stomach , 1985, British journal of pharmacology.

[19]  H. Kilbinger,et al.  Organ selectivity of hexahydrosiladifenidol in blocking pre- and postjunctional muscarinic receptors studied in guinea-pig ileum and rat heart. , 1985, European journal of pharmacology.

[20]  W. Simon,et al.  Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drug. , 1985, European journal of pharmacology.

[21]  R. Barlow,et al.  The relative potencies of some agonists at M2 muscarinic receptors in guinea‐pig ileum, atria and bronchi , 1985, British journal of pharmacology.

[22]  A. Roach,et al.  α2‐Adrenoceptor agonists induce mydriasis in the rat by an action within the central nervous system , 1983 .

[23]  R. Hammer,et al.  Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. , 1982, Life sciences.

[24]  R. Barlow,et al.  THE EFFECTS OF pH ON THE AFFINITY OF PIRENZEPINE FOR MUSCARINIC RECEPTORS IN THE GUINEA‐PIG ILEUM AND RAT FUNDUS STRIP , 1982, British journal of pharmacology.

[25]  R. Barlow,et al.  AFFINITIES OF THE PROTONATED AND NON‐PROTONATED FORMS OF HYOSCINE AND HYOSCINE N‐OXIDE FOR MUSCARINIC RECEPTORS OF THE GUINEA‐PIG ILEUM AND A COMPARISON OF THEIR SIZE IN SOLUTION WITH THAT OF ATROPINE , 1981, British journal of pharmacology.

[26]  J. Garthwaite,et al.  MUSCARINIC RECEPTORS IN RAT SYMPATHETIC GANGLIA , 1980, British journal of pharmacology.

[27]  S. Thesleff,et al.  Aminopyridines and synaptic transmission , 1980, Neuroscience.

[28]  J. Molgó,et al.  Potency of 3,4-diaminopyridine and 4-aminopyridine on mammalian neuromuscular transmission and the effect of pH changes. , 1980, European journal of pharmacology.

[29]  N. Birdsall,et al.  Pirenzepine distinguishes between different subclasses of muscarinic receptors , 1980, Nature.

[30]  R. Barlow,et al.  Three types of muscarinic receptors? [proceedings]. , 1980, British journal of pharmacology.

[31]  J. Robinson,et al.  Vehicle effects on ocular drug bioavailability II: Evaluation of pilocarpine. , 1977, Journal of pharmaceutical sciences.

[32]  P. Glenton,et al.  A COMPARISON OF AFFINITY CONSTANTS FOR MUSCARINE‐SENSITIVE ACETYLCHOLINE RECEPTORS IN GUINEA‐PIG ATRIAL PACEMAKER CELLS AT 29°C AND IN ILEUM AT 29°C AND 37°C , 1976, British journal of pharmacology.

[33]  T. Narahashi,et al.  Dynamics of aminopyridine block of potassium channels in squid axon membrane , 1976, The Journal of general physiology.

[34]  R. Marshall.  A new muscarinic agent: 1,4,5,6-tetrahydro-5-phenoxypyrimidine (AH 6405). , 1970, British journal of pharmacology.

[35]  R. S. Alphin,et al.  PHARMACOLOGIC STUDIES OF N-BENZYL-3-PYRROLIDYL ACETATE METHOBROMIDE (AHR-602), A GANGLION STIMULATING AGENT , 1963 .

[36]  A. Roszkowski.  An unusual type of sympathetic ganglionic stimulant. , 1961, The Journal of pharmacology and experimental therapeutics.

[37]  T. Tufte,et al.  Inhibition of Cholinesterases by Tetrahydroaminacrin. , 1961 .

[38]  R. Warwick,et al.  The ocular parasympathetic nerve supply and its mesencephalic sources. , 1954, Journal of Anatomy.